- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/38 - Nitrogen atoms
Patent holdings for IPC class C07D 215/38
Total number of patents in this class: 937
10-year publication summary
|
53
|
50
|
53
|
39
|
46
|
60
|
39
|
33
|
30
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10311 |
39 |
| Institut Curie | 575 |
35 |
| Abivax | 119 |
33 |
| Universite de Montpellier | 973 |
31 |
| Aldeyra Therapeutics, Inc. | 109 |
29 |
| Vertex Pharmaceuticals Incorporated | 1593 |
21 |
| Janssen Pharmaceutica N.V. | 3432 |
16 |
| Syngenta Participations AG | 1920 |
11 |
| Abbvie Inc. | 1800 |
11 |
| Bristol-myers Squibb Company | 4897 |
10 |
| Boehringer Ingelheim International GmbH | 4701 |
9 |
| Corteva Agriscience LLC | 2659 |
9 |
| F. Hoffmann-La Roche AG | 7920 |
8 |
| The Regents of the University of California | 19803 |
8 |
| Takeda Pharmaceutical Company Limited | 2703 |
8 |
| Alcon, Inc. | 5392 |
8 |
| HMI Medical Innovations, LLC | 16 |
8 |
| Merck Sharp & Dohme LLC | 3739 |
8 |
| Amgen Inc. | 4037 |
7 |
| Gilead Sciences, Inc. | 2026 |
7 |
| Other owners | 621 |